Clinical Trial Update: A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of combining semaglutide with NNC0480-0389 in adults with Type 2 diabetes mellitus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0480-0389
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2026-04-09